Medindia

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Function Compared to Budesonide Alone

TITAN study results presented at CHEST meeting represent one of few asthma studies to examine African American patients exclusively SYMBICORT is a combination asthma medication that contains both an ...
Fierce Healthcare

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
FiercePharma

Long-Term Study Demonstrates Safety and Efficacy of SYMBICORT® in African American Patients with Asthma

DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
Medscape

Budesonide/Formoterol Appears Safe, Effective for Asthma Control at 1 Year

August 22, 2008 — A budesonide/formoterol (Symbicort, AstraZeneca) pressurized metered-dose inhaler (pMDI) showed safety and better asthma control versus budesonide alone, according to the results of ...
Seeking Alpha

AstraZeneca's Symbicort successful in two late-stage studies for expanded use

AstraZeneca (NYSE:AZN) announces successful results from two clinical trials assessing the expanded use of SYMBICORT (budesonide/formoterol fumarate dihydrate ...
Business Wire

SYMBICORT Real-World Study Results Published in the International Journal of COPD

WILMINGTON, Del.--(BUSINESS WIRE)--Results from a US comparative effectiveness study of two maintenance treatment options for patients with a history of chronic obstructive pulmonary disease (COPD) ...
FierceBiotech

FDA OKs new use for Symbicort

The FDA has approved AstraZeneca's Symbicort for a new use. Symbicort can now be used to treat asthma and chronic bronchitis, making it far more competitive with the blockbuster Advair. Report Let ...
Monthly Prescribing Reference

FDA Approves Inhaler Monitoring Device for Symbicort

The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence. The Food and Drug Administration (FDA) has granted Adherium ...
Seattle Times

FDA advisers vote for ban on 2 drugs to treat asthma

ROCKVILLE, Md. — A panel of federal drug experts voted Thursday to recommend the drugs Serevent and Foradil be banned for the treatment of asthma, but the experts said Advair and Symbicort should ...
FierceBiotech

EPO Announces Symbicort European COPD Use Patent Decision

AstraZeneca today announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent covering the use of Symbicort (formoterol and ...
FiercePharma

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Functio

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...